In addition, there are other factors that affect the efficacy of immunotherapy, including the decrease of tumor-infiltrating lymphocytes, the low expression of PD-L1, and the decrease in absolute value of lymphocytes [20]. The gene discussed is CD274; the disease is neoplasm.